search
Documents
Separation of Gemifloxacin Mesylate and its Organic Impurities per USP Monograph using Luna Omega 5 µm C18 Column
Gemifloxacin Mesylate is an antimicrobial drug used to inhibit the action of topoisomerase IV. The development of a quick and efficient analysis of Gemifloxacin Mesylate and its related organic impurities is of interest for drug manufacturers. In this application note, we report the separation of Gemifloxacin Mesylate and its related organic impurities using three batches of Luna Omega C18 media according to the USP monograph for Gemifloxacin Mesylate.
Separation of Gemifloxacin Mesylate and its Organic Impurities per USP Monograph using Luna Omega 5 µm C18 Column
Gemifloxacin Mesylate is an antimicrobial drug used to inhibit the action of topoisomerase IV. The development of a quick and efficient analysis of Gemifloxacin Mesylate and its related organic impurities is of interest for drug manufacturers. In this application note, we report the separation of Gemifloxacin Mesylate and its related organic impurities using three batches of Luna Omega C18 media according to the USP monograph for Gemifloxacin Mesylate.
Document Type:
Technical Notes
Target Industries:
Techniques:
Brands:
Separation Modes:
Reversed Phase
Phases:
Phenomenex is a technology leader committed to developing novel analytical chemistry solutions that solve the separation and purification challenges of researchers worldwide
Phenomenex is a technology leader committed to developing novel analytical chemistry solutions that solve the separation and purification challenges of researchers worldwide